vimarsana.com

Sleep Inertia Visual Analog Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

KP1077 Demonstrates Safety in Idiopathic Hypersomnia Patients

The phase 2 trial explored the safety and efficacy of KP1077 in reducing daytime sleepiness and sleep inertia.

Christopher drakeZevra therapeutics incZevra therapeuticsEpworth sleepiness scaleTherapeutics incAdrian quartelSleep inertia visual analog scaleTrial highlightsBrain fog scaleExcessive daytime sleepiness

Sleep Month in Review: March 2024

This sleep month in review highlights the 6 top sleep pieces in March, from FDA news, topline data, and pieces exploring how daylight savings and long COVID impact sleep.

Drug administrationVanda pharmaceuticals incComplete response letterNew drug applicationZevra therapeuticsHypersomnia severity scaleSleep inertia visual analog scaleBrain fog severityAxsome therapeuticsForm insightsDaylight savings transitionHow longNorthwestern medicine comprehensive

Zevra Highlights Plans to Advance IH, Narcolepsy Drug Candidate

Zevra reported progress in 2023, including results from a phase 2 study for idiopathic hypersomnia and plans to expand into narcolepsy.

Neilf mcfarlaneDrug administrationZevra therapeutics incInvestigational new drugTherapeutics incEpworth sleepinessIdiopathic hypersomnia severity scaleSleep inertia visual analog scaleBrain fog

KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomnia Symptoms

A phase 2 trial found KP1077 provides clinically meaningful benefits for idiopathic hypersomnia.

United statesChristopher drakeHenry ford health christopher drakeAmerican academy of sleep medicineDrug administrationUs drug enforcement agencyHenry ford healthZevra therapeuticsAmerican academyOrphan drug designationEnforcement agencyEpworth sleepiness scaleIdiopathic hypersomnia severity scaleSleep inertia visual analog scaleEpworth sleepinessBrain fog severity scale

Zevra Therapeutics Reports Fourth Quarter and Full Year

Zevra Therapeutics Reports Fourth Quarter and Full Year
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesNeilf mcfarlaneNichol ochsnerAdannag alexanderDrug administrationExchange commissionAccess programCompany expanded access programEuropean medicines agencyCompany annual report on formUs drug enforcement agencyUniversity of washingtonZevra therapeutics incCompany quarterly reports on formPatient servicesAudit committee

vimarsana © 2020. All Rights Reserved.